CHEMINFORMATICS.ORG
Today's Pharma Headlines: FDA declines to approve Cosmo’s NDA for Methylene Blue MMX - Epigen to license LPA1 receptor small molecule program to Novo Nordisk - Cara out-licenses Korsuva injection ex-US rights to Vifor Fresenius for $520m - ...